Hesperidin protects testicular and spermatological damages induced by cisplatin in rats.
The clinic usage of cisplatin, an anticancer drug, is limited due to it has many side effects in many systems and organs. In this context, it was aimed to investigate the protective effect of hesperidin, a citrus flavonoid, on testicular and spermatological damages induced by cisplatin in rats. The rats were randomly divided into four groups. The first group was kept as a control. In the second groups, cisplatin was given at the single dose of 7 mg kg(-1) intraperitoneally. In the third group, hesperidin was orally administered at the dose of 50 mg/kg day(-1) for 14 days. In the fourth group, cisplatin and hesperidin were given together at the same doses. Cisplatin treatment caused significant reductions enzymatic (SOD, CAT and GPx) and nonenzymatic (GSH) antioxidants and significant induction level of TBARS. In addition, cisplatin treatment caused decreased sperm motility, epididymal sperm concentration, increased abnormal sperm rate and histopathological damage. In contrast, hesperidin treatment significantly attenuated the harmful effects. In conclusion, this study clearly demonstrated that hesperidin has protective effects on cisplatin-induced reproductive system toxicity depending on its antioxidant properties. Thus, it is thought that hesperidin may be useful against cisplatin toxicity in patients with cancer in terms of reproductive system.
['Kaya|K|K|', 'Ciftci|O|O|', 'Cetin|A|A|', 'Doğan|H|H|', 'Başak|N|N|']
D000818:Animals D000970:Antineoplastic Agents D002945:Cisplatin D004798:Enzymes D006569:Hesperidin D008297:Male D051381:Rats D017207:Rats, Sprague-Dawley D013094:Spermatozoa D013737:Testis D017392:Thiobarbituric Acid Reactive Substances
hesperidin Cisplatin sperm motility oxidative stress testis